Clinical trials
Phase 1 Lymphoma, B-Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arvinas Inc. | 1 |
| British Columbia Cancer Agency | 1 |
| Canadian Cancer Trials Group | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Iksuda Therapeutics Ltd. | 1 |
| Juno Therapeutics, a Subsidiary of Celgene | 1 |
| Pacylex Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 11 |
| Lymphoma, Non-Hodgkin | 9 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma | 3 |
| Lymphoma, Follicular | 3 |
| Recurrence | 2 |
| Burkitt Lymphoma | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Immunoblastic Lymphadenopathy | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.